Hsbc Holdings PLC Aclaris Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

  • $160 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.92 - $1.44 $42,649 - $66,755
46,358 New
46,358 $57,000
Q3 2023

Nov 13, 2023
SELL
$6.56 - $10.95 $21,352 - $35,642
-3,255 Reduced 1.3%
246,587 $1.69 Million
Q2 2023

Aug 11, 2023
BUY
$7.89 - $10.64 $1.97 Million - $2.66 Million
249,842 New
249,842 $2.59 Million

Others Institutions Holding ACRS

# of Institutions
97
Shares Held
52.4M
Call Options Held
32.4K
Put Options Held
3.3K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email